• Key Features & Attributes
  • Ratings & Reviews
  • Know your Supplier
  • Product description from supplier

GLIPVAS 50 TAB - Dr Precision

Inclusive of all taxes

GLIPVAS 50 TAB - Dr Precision is a premium pharmaceutical tablet containing 50 mg of Vildagliptin, a potent DPP-4 inhibitor specifically formulated for the management of Type 2 Diabetes Mellitus (T2DM). Manufactured by BluepillExpress under strict GMP and WHO-GMP standards, this advanced antidiabetic medication offers reliable glycemic control either as monotherapy or in combination therapy with metformin, sulfonylureas, or thiazolidinediones. By inhibiting the DPP-4 enzyme, GLIPVAS 50 TAB enhances incretin hormones such as GLP-1 and GIP, thereby increasing insulin secretion and lowering glucagon production post meals. This precise formulation supports significant reductions in fasting and postprandial blood glucose levels, making it ideal for patients inadequately controlled by diet and exercise. With rapid absorption and excellent bioavailability, GLIPVAS 50 ensures effective, predictable plasma drug levels. It is designed for oral administration, with flexibility in dosing once or twice daily depending on patient needs and renal function status. Exported globally to distributors, hospitals, and pharmacies across Asia, Africa, Middle East, and LATAM, GLIPVAS 50 TAB upholds international quality and safety standards, making it a trusted choice for healthcare professionals and pharmaceutical suppliers seeking efficacious and export-compliant Vildagliptin tablets.

Key Features

Features Description
Active Ingredient Vildagliptin 50 mg
Drug Class DPP-4 Inhibitor
Indication Type 2 Diabetes Mellitus (T2DM) management
Manufacturing Compliance WHO-GMP and ISO Certified by BluepillExpress
Dosage Form Oral Tablet
Administration Once or twice daily with or without food
Pharmacokinetics Rapid absorption with peak plasma level at 1.5 hours, bioavailability approx. 85%, half-life 2-3 hours
Mechanism of Action Inhibits DPP-4 enzyme increasing incretin hormone levels, enhancing insulin secretion and reducing glucagon
Therapeutic Use Monotherapy or add-on therapy with Metformin, Sulfonylureas, Thiazolidinediones
Export Ready Meets international regulatory standards for global distribution
Attributes Description
Brand Dr Precision
Manufacturer BluepillExpress
Tablet Strength 50 mg Vildagliptin
Packaging Available in bulk for B2B supply
Storage Conditions Store below 30°C, protect from moisture
Shelf Life Minimum 2 years from manufacturing date
Regulatory Compliance WHO-GMP, ISO Certified
Renal Adjustment Dose modification required in renal impairment
Not Recommended For Type 1 Diabetes and Diabetic Ketoacidosis
Elimination Route Renal (unchanged drug and metabolites)

*Disclaimer: The above description has been AI-generated and has not been audited or verified for accuracy. It is recommended to verify product details independently before making any purchasing decisions.

Be the first to write a review

Yes, GLIPVAS 50 TAB is designed to be used as monotherapy or as an add-on therapy with agents like metformin, sulfonylureas, or thiazolidinediones to enhance glycemic control.

Yes, dosing modifications for GLIPVAS 50 TAB are recommended in patients with renal impairment to ensure safety and therapeutic efficacy.

The bioavailability of Vildagliptin in GLIPVAS 50 TAB is approximately 85%, with rapid absorption achieving peak plasma concentration around 1.5 hours post-dose.

Yes, GLIPVAS 50 TAB is manufactured under strict WHO-GMP and ISO certification with regulatory compliance suitable for export to multiple international markets.

No, GLIPVAS 50 TAB is not recommended for patients with Type 1 Diabetes or diabetic ketoacidosis.

  • Incorporation Type

  • GST

  • GST Registration Date

  • Number of Employees

  • Import Export Code (IEC)

  • Year of Establishment

  • Nature of Business

  • GlobalLinker Member Since

Country Of Origin: India

GLIPVAS 50 TAB is a high-quality pharmaceutical tablet containing Vildagliptin 50 mg, an advanced DPP-4 inhibitor used in the effective management of Type 2 Diabetes Mellitus. Formulated and manufactured by BluepillExpress, this antidiabetic tablet offers reliable glycemic control, either as monotherapy or in combination with other agents like metformin or sulfonylureas. Exported globally, it meets international regulatory standards for quality, safety, and efficacy.


This product is manufactured under the Dr Precision label, ensuring GMP-compliant quality and precision formulation standards.

GLIPVAS 50 TAB is a potent oral antidiabetic formulation comprising Vildagliptin 50 mg, a member of the DPP-4 (Dipeptidyl Peptidase-4) inhibitor class, used extensively in the treatment of Type 2 Diabetes Mellitus (T2DM). It helps regulate blood sugar levels by enhancing the body’s natural incretin system, thereby improving insulin secretion and reducing glucagon levels after meals.


This formulation is produced by BluepillExpress, a globally reputed third-party pharmaceutical manufacturing company, compliant with WHO-GMP and ISO quality systems. Known for its consistency and robust export capabilities, BluepillExpress supplies GLIPVAS 50 TAB to distributors, hospitals, pharmacies, and tender markets across Asia, Africa, the Middle East, LATAM, and more.


Mechanism of Action

Vildagliptin inhibits the DPP-4 enzyme, which is responsible for the rapid degradation of incretin hormones such as GLP-1 and GIP. By increasing the concentration of these hormones, it enhances glucose-dependent insulin secretion from pancreatic beta cells and suppresses glucagon release from alpha cells. This results in a reduction of both fasting and postprandial blood glucose levels.


Indications

Type 2 Diabetes Mellitus (as monotherapy or combination therapy)


For patients inadequately controlled with diet and exercise alone


Suitable as an add-on to Metformin, Sulfonylureas, or Thiazolidinediones


Dosage and Administration

Recommended Dose: 50 mg once or twice daily depending on glycemic control needs


Maximum Dose: 100 mg/day


Administered orally, with or without food


Dosage adjustment required in renal impairment


Not recommended in patients with Type 1 Diabetes or Diabetic Ketoacidosis


Pharmacokinetics

Absorption: Rapid, with peak plasma concentration within 1.5 hours


Bioavailability: Approximately 85%


Elimination: Primarily via kidneys (unchanged and metabolites)


Half-life: 2-3 hours



Mobile Phone And Accessories

GLIPVAS 50 TAB

Vildagliptin 50 Mg Tablet

Dr Precision Vildagliptin

Type 2 Diabetes Medicine

DPP-4 Inhibitor Tablets

Antidiabetic Tablets Wholesale

BluepillExpress Vildagliptin

Oral Diabetes Medication

Glycemic Control Tablets

GLIPVAS 50 TAB - Dr Precision

Inclusive of all taxes

You Save: 0

Send Inquiry
bluepill express

Surat , India

Manufacturer, Contractor, Retailer, Brand Owner, Distributor, Exporter, Importer, Wholesaler, Startup

GST- 24abdfb4194j1ze

  • Secure
    Transaction

  • Free
    Delivery

  • Day
    Dispatch

Report a problem with this product